222 top medical experts on Porphyria Cutanea Tarda across 31 countries and 21 U.S. states, including 69 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Porphyria Cutanea Tarda: An autosomal dominant or acquired porphyria due to a deficiency of uroporphyrinogen decarboxylase in the liver. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Hepatic Porphyrias (226).
  4. Clinical Trials ClinicalTrials.gov : at least 6 including 2 Active, 3 Completed


  

        

                    


    Computing Expert Listing ...

);